Bioequivalence and Food Effect Assessment Between 2 Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Chinese Subjects

Documenti analoghi

• Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Vildagliptin in Healthy Chinese Subjects
  di: Mengli Tian, et al.
  Pubblicazione: (2024)
• Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults
  di: Huizi Zhang, et al.
  Pubblicazione: (2024)
• The Bioequivalence of Abexinostat (CRA‐024781) Tosylate Tablets (20 mg) in Chinese Healthy Subjects Under Fasting Conditions
  di: Xiang Li, et al.
  Pubblicazione: (2024)
• Bioequivalence Study of Bedaquiline Fumarate Tablets in Healthy Chinese Subjects
  di: Man Yang, et al.
  Pubblicazione: (2025)
• Pharmacokinetics, Bioequivalence, and Safety of Levothyroxine Sodium Tablets in Healthy Chinese Subjects
  di: Juan Jin, et al.
  Pubblicazione: (2025)